{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:38:43Z","timestamp":1771666723573,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.clinre.2024.102373","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T06:45:44Z","timestamp":1715064344000},"page":"102373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Vonoprazan causes symptomatic improvement in non-erosive gastroesophageal reflux disease: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0812-2810","authenticated-orcid":false,"given":"Sanjay","family":"Bandyopadhyay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Verma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shambo Samrat","family":"Samajdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3153-4166","authenticated-orcid":false,"given":"Saibal","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2024.102373_bib0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5056\/jnm.2010.16.1.8","article-title":"Nonerosive reflux disease (NERD) - an update","volume":"16","author":"Hershcovici","year":"2010","journal-title":"J Neurogastroenterol"},{"key":"10.1016\/j.clinre.2024.102373_bib0002","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","article-title":"The Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus","volume":"101","author":"Vakil","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102373_bib0003","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/ajg.2009.504","article-title":"Quality of life in GERD and Barrett's esophagus is related to gender and manifestation of disease","volume":"104","author":"Lippmann","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102373_bib0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.5056\/jnm21095","article-title":"On-demand versus continuous maintenance treatment of gastroesophageal reflux disease with proton pump inhibitors: a systematic review and meta-analysis","volume":"28","author":"Kang","year":"2022","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.clinre.2024.102373_bib0005","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5056\/jnm15105","article-title":"Unmet needs in the treatment of gastroesophageal reflux disease","volume":"21","author":"Dickman","year":"2015","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.clinre.2024.102373_bib0006","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0002-9343(97)00354-9","article-title":"The impact of gastroesophageal reflux disease on health-related quality of life","volume":"104","author":"Revicki","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.clinre.2024.102373_bib0007","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.14309\/ajg.0000000000000619","article-title":"Gastroesophageal reflux disease-functional dyspepsia overlap: do birds of a feather flock together?","volume":"115","author":"Geeraerts","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102373_bib0008","article-title":"Proton pump inhibitors for functional dyspepsia","volume":"11","author":"Pinto-Sanchez","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinre.2024.102373_bib0009","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/87551225231166531","article-title":"Vonoprazan: a new potassium-competitive acid blocker","volume":"39","author":"St Onge","year":"2023","journal-title":"J Pharm Technol"},{"key":"10.1016\/j.clinre.2024.102373_bib0010","doi-asserted-by":"crossref","first-page":"e00101","DOI":"10.14309\/ctg.0000000000000101","article-title":"Efficacy and safety of vonoprazan in patients with nonerosive gastroesophageal reflux disease: a randomized, placebo-controlled, phase 3 study","volume":"10","author":"Kinoshita","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102373_bib0011","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.clinre.2024.102373_bib0012","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.clinre.2024.102373_bib0013","unstructured":"The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from Ottawa Hospital Research Institute (ohri.ca) (Accessed 1 February 2024)."},{"key":"10.1016\/j.clinre.2024.102373_bib0014","series-title":"Cochrane handbook for systematic reviews of interventions Version 5.1.0 [updated March 2011]","author":"Higgins","year":"2011"},{"key":"10.1016\/j.clinre.2024.102373_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clinre.2024.102373_bib0016","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.clinre.2024.102373_bib0017","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinre.2024.102373_bib0018","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jclinepi.2013.02.003","article-title":"GRADE guidelines: 15. Going from evidence to recommendation-determinants of a recommendation's direction and strength","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.clinre.2024.102373_bib0019","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1111\/apt.17728","article-title":"Randomised clinical trial: efficacy and safety of on-demand vonoprazan versus placebo for non-erosive reflux disease","volume":"58","author":"Fass","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2024.102373_bib0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3892\/br.2021.1408","article-title":"Long-term vonoprazan therapy is effective for controlling symptomatic proton pump inhibitor-resistant gastroesophageal reflux disease","volume":"14","author":"Shinozaki","year":"2021","journal-title":"Biomed Rep"},{"key":"10.1016\/j.clinre.2024.102373_bib0021","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1159\/000506152","article-title":"The ameliorating effect of switching to vonoprazan: a novel potassium-competitive acid blocker in patients with proton pump inhibitor refractory non-erosive reflux disease","volume":"102","author":"Abe","year":"2021","journal-title":"Digestion"},{"key":"10.1016\/j.clinre.2024.102373_bib0022","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000503340","article-title":"Clinical characterization of vonoprazan-refractory gastroesophageal reflux disease","volume":"102","author":"Hamada","year":"2021","journal-title":"Digestion"},{"key":"10.1016\/j.clinre.2024.102373_bib0023","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s10388-018-00654-9","article-title":"Efficacy of on-demand therapy using 20-mg vonoprazan for non-erosive reflux disease","volume":"16","author":"Hoshikawa","year":"2019","journal-title":"Esophagus"},{"key":"10.1016\/j.clinre.2024.102373_bib0024","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/00365521.2018.1486883","article-title":"Long-term outcomes of patients with symptomatic gastroesophageal reflux disease treated with vonoprazan","volume":"53","author":"Shinozaki","year":"2018","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102373_bib0025","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.2169\/internalmedicine.0492-17","article-title":"Efficacy of vonoprazan for gastroesophageal reflux symptoms in patients with proton pump inhibitor-resistant non-erosive reflux disease","volume":"57","author":"Niikura","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.clinre.2024.102373_bib0026","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.kjms.2017.07.004","article-title":"Vonoprazan treatment improves gastrointestinal symptoms in patients with gastroesophageal reflux disease","volume":"33","author":"Shinozaki","year":"2017","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.clinre.2024.102373_bib0027","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3892\/br.2016.828","article-title":"Efficacy of a potassium-competitive acid blocker for improving symptoms in patients with reflux esophagitis, non-erosive reflux disease, and functional dyspepsia","volume":"6","author":"Asaoka","year":"2017","journal-title":"Biomed Rep"},{"key":"10.1016\/j.clinre.2024.102373_bib0028","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5056\/jnm.2010.16.1.8","article-title":"Nonerosive Reflux Disease (NERD) - An Update","volume":"16","author":"Hershcovici","year":"2010","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.clinre.2024.102373_bib0029","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/653989","article-title":"Current advances in the diagnosis and treatment of nonerosive reflux disease","volume":"2013","author":"Chen","year":"2013","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/j.clinre.2024.102373_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1177\/0897190017692921","article-title":"Efficacy and Safety of Patiromer in Hyperkalemia: a Systematic Review and Meta-Analysis","volume":"31","author":"Das","year":"2018","journal-title":"J Pharm Pract"},{"key":"10.1016\/j.clinre.2024.102373_bib0031","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11894-008-0044-5","article-title":"Nonerosive reflux disease: a pathophysiologic perspective","volume":"10","author":"Long","year":"2008","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.clinre.2024.102373_bib0032","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5056\/jnm18139","article-title":"Role of acid suppression in acid-relates diseases: proton pump inhibitor and potassium-competitive acid blocker","volume":"25","author":"Mori","year":"2019","journal-title":"J Neurogastroenterol Motil"},{"key":"10.1016\/j.clinre.2024.102373_bib0033","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/14656566.2017.1346087","article-title":"Vonoprazan fumarate for the management of acid related diseases","volume":"18","author":"Martinucci","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clinre.2024.102373_bib0034","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/gut.2007.145581","article-title":"Management of heartburn not responding to proton pump inhibitors","volume":"58","author":"Fass","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2024.102373_bib0035","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00535-016-1227-8","article-title":"Evidence based clinical practice guidelines for gastroesophageal reflux disease 2015","volume":"51","author":"Iwakiri","year":"2016","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102373_bib0036","article-title":"Proton pump inhibitors for functional dyspepsia","volume":"11","author":"Pinto Sanchez","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinre.2024.102373_bib0037","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2036.2007.03367.x","article-title":"Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects","volume":"26","author":"Miwa","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2024.102373_bib0038","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00535-008-2303-5","article-title":"Real time evaluation of dyspeptic symptoms and gastric motility induced by duodenal acidification using noninvasive transnasal endoscopy","volume":"43","author":"Ishii","year":"2008","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.clinre.2024.102373_bib0039","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/apt.13588","article-title":"Potent acid inhibition by vonoprazan in comparison with esomeprazole, with reference to CYP2C19 genotype","volume":"43","author":"Kagami","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2024.102373_bib0040","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/apt.15641","article-title":"Randomised trial of acid inhibition by vonoprazan 10\/20 mg once daily vs rabeprazole 10\/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)","volume":"51","author":"Takeuchi","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"issue":"52","key":"10.1016\/j.clinre.2024.102373_bib0041","first-page":"59","article-title":"The Effects of switching to vonoprazan, a novel potassium competitive acid blocker, on gastric acidity and reflux patterns in patients with erosive esophagitis refractory to proton pump inhibitors","volume":"96","author":"Matsumoto","year":"2017","journal-title":"Digestion"},{"key":"10.1016\/j.clinre.2024.102373_bib0042","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/apt.13325","article-title":"Acid inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects a randomised open label cross over study","volume":"42","author":"Sakurai","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinre.2024.102373_bib0043","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000456072","article-title":"Efficacy of vonoprazan for proton pump inhibitor resistant reflux esophagitis","volume":"95","author":"Hoshikawa","year":"2017","journal-title":"Digestion"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T15:57:06Z","timestamp":1717343826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2210740124000949"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102373","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vonoprazan causes symptomatic improvement in non-erosive gastroesophageal reflux disease: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102373"}}